You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 20, 2024

Investigational Drug Information for Ralinepag

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ralinepag?

Ralinepag is an investigational drug.

There have been 6 clinical trials for Ralinepag. The most recent clinical trial was a Phase 2 trial, which was initiated on August 30th 2018.

The most common disease conditions in clinical trials are Pulmonary Arterial Hypertension, Hypertension, and Familial Primary Pulmonary Hypertension. The leading clinical trial sponsors are United Therapeutics, Arena Pharmaceuticals, and Everstar Medicines (Shanghai) Limited.

There is one US patent protecting this investigational drug and fifty-eight international patents.

Recent Clinical Trials for Ralinepag
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PHUnited TherapeuticsPhase 3
A Study of Ralinepag in Healthy Chinese Audlt SubjectsEverstar Medicines (Shanghai) LimitedPhase 1
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionUnited TherapeuticsPhase 3

See all Ralinepag clinical trials

Clinical Trial Summary for Ralinepag

Top disease conditions for Ralinepag
Top clinical trial sponsors for Ralinepag

See all Ralinepag clinical trials

International Patents for Ralinepag

Drugname Country Document Number Estimated Expiration Related US Patent
Ralinepag Australia AU2017261372 2036-05-05 ⤷  Sign Up
Ralinepag Canada CA3023278 2036-05-05 ⤷  Sign Up
Ralinepag China CN107847398 2036-05-05 ⤷  Sign Up
Ralinepag European Patent Office EP3452003 2036-05-05 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.